Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT06685653
What this trial is testing

Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

Who this might be right for
NSCLC
Nanjing Tianyinshan Hospital 65
Early research (Phase 1)Looking for participantsNCT07203755
What this trial is testing

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Who this might be right for
Diphtheria, Tetanus and Acellular PertussisEpidemic MeningitisHaemophilus Influenzae Type B Infection
CanSino Biologics Inc. 260
Early research (Phase 1)Ended earlyNCT03948763
What this trial is testing

MRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms+1 more
Merck Sharp & Dohme LLC 70
Testing effectiveness (Phase 2)Study completedNCT00078585
What this trial is testing

PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Bavarian Nordic 120
Early research (Phase 1)Study completedNCT00001021
What this trial is testing

A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 57
Testing effectiveness (Phase 2)Study completedNCT01696877
What this trial is testing

A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer

Who this might be right for
Prostate Cancer Adenocarcinoma in Situ
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 29
Early research (Phase 1)Looking for participantsNCT06514898
What this trial is testing

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Who this might be right for
Recurrent Group 3 MedulloblastomaRecurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma
University of Florida 12
Not applicableLooking for participantsNCT06751914
What this trial is testing

Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Early research (Phase 1)Study completedNCT00073216
What this trial is testing

Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 96
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Post-approval studies (Phase 4)Study completedNCT00684671
What this trial is testing

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

Who this might be right for
Hepatitis AHepatitis B
GlaxoSmithKline 506
Testing effectiveness (Phase 2)Looking for participantsNCT04669171
What this trial is testing

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Enterome 80
Testing effectiveness (Phase 2)Study completedNCT00952692
What this trial is testing

Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Michael Morse, MD 12
Large-scale testing (Phase 3)Study completedNCT00169728
What this trial is testing

Vaccination of Children Following Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Haematopoietic Stem Cell Transplantation
Heinrich-Heine University, Duesseldorf 53
Testing effectiveness (Phase 2)WithdrawnNCT03169777
What this trial is testing

QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

Who this might be right for
Colorectal Cancer
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT05903183
What this trial is testing

Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age

Who this might be right for
Healthy
Icosavax, Inc. 264
Large-scale testing (Phase 3)UnknownNCT00005002
What this trial is testing

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 688
Testing effectiveness (Phase 2)UnknownNCT01924156
What this trial is testing

DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Large-scale testing (Phase 3)Study completedNCT00259337
What this trial is testing

Immunogenicity and Safety of Pentaxim™ in an Indian Population

Who this might be right for
DiphtheriaTetanusPolio+2 more
Sanofi 226
Early research (Phase 1)Active Not RecruitingNCT03361852
What this trial is testing

Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Dana-Farber Cancer Institute 20
Next Page